Literature DB >> 10717292

The avian response to Newcastle disease virus.

B S Seal1, D J King, H S Sellers.   

Abstract

Newcastle disease virus (NDV) is classified as a member of the superfamily Mononegavirales in the family Paramyxoviridae. This virus family is divided into two subfamilies, the Paramyxovirinae and the Pneumovirinae. In 1993 the International Committee on the Taxonomy of Viruses rearranged the order of the Paramyxovirus genus and placed NDV within the Rubulavirus genus among the Paramyxovirinae. The enveloped virus has a negative sense single-stranded RNA genome of 15,186 kb which codes for an RNA directed RNA polymerase, hemagglutinin-neuraminidase protein, fusion protein, matrix protein, phosphoprotein and nucleoprotein in the 5' to 3' direction. The virus has a wide host range with most orders of birds reported to have been infected by NDV. Isolates are characterized by virulence in chickens and are categorized into three main pathotypes depending on severity of disease. Lentogenic isolates are of low virulence while viruses of intermediate virulence are termed mesogenic. Highly virulent viruses that cause high mortality in birds are termed neurotropic or viscerotropic velogenic. Velogenic NDV are List A pathogens that require reporting to the Office of International Epizootics and outbreaks result in strict trade embargoes. The primary molecular determinant for NDV pathogenicity is the fusion protein cleavage site amino acid sequence. Vaccination for NDV is primarily by mass application of live-virus vaccines among commercial poultry. Although protection is measured by presence of antibodies to NDV, vaccinated B-cell depleted chickens are resistant to disease. Consequently, immune protection involves responses that are presently incompletely defined.

Entities:  

Mesh:

Year:  2000        PMID: 10717292     DOI: 10.1016/s0145-305x(99)00077-4

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  45 in total

1.  Complete genome characterisation of a Newcastle disease virus isolated during an outbreak in Sweden in 1997.

Authors:  Anna-Malin Linde; Muhammad Munir; Siamak Zohari; Karl Ståhl; Claudia Baule; Lena Renström; Mikael Berg
Journal:  Virus Genes       Date:  2010-07-17       Impact factor: 2.332

2.  Molecular characterization of virulent Newcastle disease virus isolates from chickens during the 1998 NDV outbreak in Kazakhstan.

Authors:  Andrey Bogoyavlenskiy; Vladimir Berezin; Alexey Prilipov; Eugeniy Usachev; Olga Lyapina; Svetlana Levandovskaya; Ilya Korotetskiy; Valentina Tolmacheva; Nailya Makhmudova; Svetlana Khudyakova; Gulnur Tustikbaeva; Irina Zaitseva; Elmira Omirtaeva; Olga Ermakova; Klara Daulbaeva; Saule Asanova; Aydyn Kydyrmanov; Marat Sayatov; Daniel King
Journal:  Virus Genes       Date:  2005-08       Impact factor: 2.332

3.  Recombinant Newcastle disease virus as a vaccine vector.

Authors:  T Nakaya; J Cros; M S Park; Y Nakaya; H Zheng; A Sagrera; E Villar; A García-Sastre; P Palese
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Buggy Creek virus (Togaviridae: Alphavirus) upregulates expression of pattern recognition receptors and interferons in House Sparrows (Passer domesticus).

Authors:  Carol A Fassbinder-Orth; Virginia A Barak; Ellecia L Rainwater; Ashley M Altrichter
Journal:  Vector Borne Zoonotic Dis       Date:  2014-05-27       Impact factor: 2.133

5.  RIG-I mediates nonsegmented negative-sense RNA virus-induced inflammatory immune responses of primary human astrocytes.

Authors:  Samantha R Furr; Megan Moerdyk-Schauwecker; Valery Z Grdzelishvili; Ian Marriott
Journal:  Glia       Date:  2010-10       Impact factor: 7.452

6.  Nucleotide mutation analyses of isolated lentogenic newcastle disease virus in live bird market.

Authors:  Jola Rahmahani; Aisyah Nikmatuz Zahro; Indah Laili Rahmawati; Nurvita Putih; Innah Wulandari; Fedik Abdul-Rantam
Journal:  Mol Biol Res Commun       Date:  2020-12

7.  Antitumor and immunostimulatory activities of a genotype V recombinant attenuated veterinary Newcastle disease virus vaccine.

Authors:  Oscar Antonio Ortega-Rivera; J Luis Quintanar; Susana Del Toro-Arreola; Ángel G Alpuche-Solis; Mayra J Esparza-Araiza; Eva Salinas
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

8.  Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.

Authors:  Mostafa Jarahian; Carsten Watzl; Philippe Fournier; Annette Arnold; Dominik Djandji; Sarah Zahedi; Adelheid Cerwenka; Annette Paschen; Volker Schirrmacher; Frank Momburg
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

9.  Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor.

Authors:  Mohd Azmir Arifin; Maizirwan Mel; Mohamed Ismail Abdul Karim; Aini Ideris
Journal:  J Biomed Biotechnol       Date:  2010-06-10

10.  Nucleotide and predicted amino acid sequence analysis of the fusion protein and hemagglutinin-neuraminidase protein genes among Newcastle disease virus isolates. Phylogenetic relationships among the Paramyxovirinae based on attachment glycoprotein sequences.

Authors:  Bruce S Seal
Journal:  Funct Integr Genomics       Date:  2004-04-24       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.